Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral heterogeneity after targeted therapy in murine cancer models with differing degrees of malignancy
Authors
Keywords
-
Journal
Translational Oncology
Volume 37, Issue -, Pages 101773
Publisher
Elsevier BV
Online
2023-09-02
DOI
10.1016/j.tranon.2023.101773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Profiling specific cell populations within the inflammatory tumor microenvironment by oscillating-gradient diffusion-weighted MRI
- (2023) Emily Hoffmann et al. Journal for ImmunoTherapy of Cancer
- T1 mapping as a surrogate marker of chemotherapy response evaluation in patients with osteosarcoma
- (2022) Esha Baidya Kayal et al. EUROPEAN JOURNAL OF RADIOLOGY
- Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer
- (2021) Justyna Błach et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Multiparametric Magnetic Resonance Imaging for Immediate Target Hit Assessment of CD13—Targeted Tissue Factor tTF-NGR in Advanced Malignant Disease
- (2021) Mirjam Gerwing et al. Cancers
- Personalized Medicine: Recent Progress in Cancer Therapy
- (2020) Valentina Gambardella et al. Cancers
- Noninvasive MRI native T1 mapping detects response to MYCN-targeted therapies in the Th-MYCN model of neuroblastoma
- (2020) Konstantinos Zormpas-Petridis et al. CANCER RESEARCH
- A decade of immune-checkpoint inhibitors in cancer therapy
- (2020) Caroline Robert Nature Communications
- Heterogeneity analysis of MRI T2 maps for measurement of early tumor response to radiotherapy
- (2020) Michal R. Tomaszewski et al. NMR IN BIOMEDICINE
- Cardiac Myxomas Show Elevated Native T1, T2 Relaxation Time and ECV on Parametric CMR
- (2020) Sarah B. Nasser et al. Frontiers in Cardiovascular Medicine
- The beginning of the end for conventional RECIST — novel therapies require novel imaging approaches
- (2019) Mirjam Gerwing et al. Nature Reviews Clinical Oncology
- Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma
- (2018) Li-Fang Wu et al. EUROPEAN RADIOLOGY
- Histogram Analysis Parameters Apparent Diffusion Coefficient for Distinguishing High and Low-Grade Meningiomas: A Multicenter Study
- (2018) Alexey Surov et al. Translational Oncology
- Advanced MRI assessment to predict benefit of anti-programmed cell death 1 protein immunotherapy response in patients with recurrent glioblastoma
- (2017) Lei Qin et al. NEURORADIOLOGY
- Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
- (2017) Maria Kissel et al. Oncotarget
- Heterogeneity of Diffusion-Weighted Imaging in Tumours and the Surrounding Stroma for Prediction of Ki-67 Proliferation Status in Breast Cancer
- (2017) Ming Fan et al. Scientific Reports
- Changes of T2 Relaxation Time From Neoadjuvant Chemotherapy in Breast Cancer Lesions
- (2016) Li Liu et al. Iranian Journal of Radiology
- Assessment of early therapeutic response to sorafenib in renal cell carcinoma xenografts by dynamic contrast-enhanced and diffusion-weighted MR imaging
- (2015) T Y Jeon et al. BRITISH JOURNAL OF RADIOLOGY
- Diffusion-weighted imaging: Apparent diffusion coefficient histogram analysis for detecting pathologic complete response to chemoradiotherapy in locally advanced rectal cancer
- (2015) Moon Hyung Choi et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Optical In Vivo Imaging of the Alarmin S100A9 in Tumor Lesions Allows for Estimation of the Individual Malignant Potential by Evaluation of Tumor-Host Cell Interaction
- (2015) A. Becker et al. JOURNAL OF NUCLEAR MEDICINE
- Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model
- (2015) Murali K. Ravoori et al. PLoS One
- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
- (2015) Anwar R. Padhani et al. NEOPLASIA
- NucleusJ: an ImageJ plugin for quantifying 3D images of interphase nuclei
- (2014) Axel Poulet et al. BIOINFORMATICS
- Tumour T1 changes in vivo are highly predictive of response to chemotherapy and reflect the number of viable tumour cells – a preclinical MR study in mice
- (2014) Claudia Weidensteiner et al. BMC CANCER
- Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma
- (2014) Yi-lei Zhao et al. Journal of Zhejiang University-SCIENCE B
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Diffusion MRI and Novel Texture Analysis in Osteosarcoma Xenotransplants Predicts Response to Anti-Checkpoint Therapy
- (2013) Parastou Foroutan et al. PLoS One
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Normalization of the Vasculature for Treatment of Cancer and Other Diseases
- (2011) Shom Goel et al. PHYSIOLOGICAL REVIEWS
- Diffusion and perfusion MRI of the lung and mediastinum
- (2010) Thomas Henzler et al. EUROPEAN JOURNAL OF RADIOLOGY
- ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
- (2010) Martha Nowosielski et al. NEURORADIOLOGY
- Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenib
- (2009) Marius Horger et al. BMC CANCER
- Correlation of ADC and T2 Measurements With Cell Density in Prostate Cancer at 3.0 Tesla
- (2009) Peter Gibbs et al. INVESTIGATIVE RADIOLOGY
- Sunitinib Reverses Type-1 Immune Suppression and Decreases T-Regulatory Cells in Renal Cell Carcinoma Patients
- (2008) J. H. Finke et al. CLINICAL CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More